Autopsy report · NCT02902484

Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer

“The study was terminated due to futility and lack of future funding”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year before it started.
• Ran for about 4 years 2 months before it stopped.
• 14 participants enrolled.
• Results were posted on the registry 2 years 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

University of Texas Southwestern Medical Center

Sponsor type

University, hospital or other

Conditions

Cancer of Pancreas

Interventions

Nintedanib

Participants

14

Sites

1

Countries

United States

Trials that died the same way

• Trial to Evaluate UltraSound in the Treatment of Tibial Fractures
  “Study was terminated due to futility” (92% match in meaning)
• Therapeutic Exercise in Patients With Hemophilia
  “The Study was terminated due to lack of funding for continuing” (91% match in meaning)
• Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
  “This study was terminated early due to futility.” (88% match in meaning)
• PET Imaging of Extrathalamic α4β2-nicotinic Acetylcholine Receptors in Health and Disease With [18F]XTRA
  “We terminated the study due to lack of funding” (88% match in meaning)
• Transverse Abdominal Plane Anesthesia for Abdominal Wall Reconstruction
  “funding for the study was terminated” (88% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.